Actinobacterial enzyme inhibitors--a review

Crit Rev Microbiol. 2015 Jun;41(2):261-72. doi: 10.3109/1040841X.2013.837425. Epub 2014 Feb 4.

Abstract

Actinobacteria have potential as important new sources of enzyme inhibitors. Enzyme inhibitors have great demand in medicine, agriculture and biotechnology. In medicine, enzyme inhibitors can be used as therapeutic agents for bacterial, fungal, viral and parasitic diseases as well as treating cancer, neurodegenerative, immunological and cardiovascular diseases. Enzyme inhibitors are also valuable for the control of carbohydrate-dependent diseases such as diabetes, obesity and hyperlipidemia and melanogenesis in skin. They can be also involved in crop protection against plant pathogens, herbivorous pests and abiotic stresses such as drought. In this review, we discuss about several actinobacterial enzyme inhibitors with various industrial uses and biotechnological applications.

Keywords: Actinobacteria; amylase inhibitors; enzyme inhibitors; medicine.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Actinobacteria / metabolism*
  • Agriculture / methods
  • Biological Products / isolation & purification
  • Biological Products / metabolism*
  • Biological Products / pharmacology*
  • Diagnostic Tests, Routine / methods
  • Drug Therapy / methods
  • Enzyme Inhibitors / isolation & purification
  • Enzyme Inhibitors / metabolism*
  • Enzyme Inhibitors / pharmacology*

Substances

  • Biological Products
  • Enzyme Inhibitors